a b c d e f g h i j k l m n o p q r s t u v w x y z #

Items starting with F Files

FEIBA (Factor VIII Inhibitor Bypassing Activity) Powder and solvent for solution for intravenous injection 500U F2U023AF

  • Date of Issuance: 24-Sep-19

FEIBA (Factor VIII Inhibitor Bypassing Activity) Powder and solvent for solution for intravenous injection 500U F2U041AG

  • Date of Issuance: 3-Dec-19

FEIBA (Factor VIII Inhibitor Bypassing Activity) Powder and solvent for solution for intravenous injection 500U F2U050AB

  • Date of Issuance: 10-Mar-20

FEIBA (Factor VIII Inhibitor Bypassing Activity) Powder and solvent for solution for intravenous injection 500U F2V032AE

  • Date of Issuance: 24-Nov-20

FEIBA (Factor VIII Inhibitor Bypassing Activity) Powder and solvent for solution for intravenous injection 500U F2V055AJ

  • Date of Issuance: 31-May-21

FEIBA (Factor VIII Inhibitor Bypassing Activity) Powder and solvent for solution for intravenous injection 500U F2V057AD

  • Date of Issuance: 12-Mar-21

FEIBA (Factor VIII Inhibitor Bypassing Activity) Powder and solvent for solution for intravenous injection 500U F2W014AA

  • Date of Issuance: 12-Jul-21

FEIBA (Factor VIII Inhibitor Bypassing Activity) Powder and solvent for solution for intravenous injection 500U F2W027AK

  • Date of Issuance: 16-Nov-21

FEIBA (Factor VIII Inhibitor Bypassing Activity) Powder and solvent for solution for intravenous injection 500U F2W029AG

  • Date of Issuance: 08-Dec-2021

FEIBA (Factor VIII Inhibitor Bypassing Activity) Powder and solvent for solution for intravenous injection 500U F2W042AB

  • Date of Issuance: 4 April 2022

FEIBA (Factor VIII Inhibitor Bypassing Activity) Powder and solvent for solution for intravenous injection 500U F2W056AB

  • Date of Issuance: 4 April 2022

FEIBA (Factor VIII Inhibitor Bypassing Fraction) Powder for Injection 500 U VNF2S008

  • Date of Issuance: 20-Jun-17

FEIBA (Factor VIII Inhibitor Bypassing Fraction) Powder for Injection 500 U VNF2S030

  • Date of Issuance: 7-Nov-17

FEIBA Powder and solvent for solution for intravenous injection 500U F2W025AA

  • Date of Issuance: 10-Sept-21

Flebogamma 5% DIF A4GBD00191

  • Date of Issuance: 3-Sep-19
<<  1 [23 4 5 6  >>  

National Pharmaceutical Regulatory Agency (NPRA)

Lot 36, Jalan Universiti (Jalan Profesor Diraja Ungku Aziz), 46200 Petaling Jaya, Selangor, Malaysia.

  • Email: npra@npra.gov.my
  • Phone: +603-7883 5400
  • Fax: +603-7956 2924, +603-7956 7075

 

 

Image   Image   Image   Image  

DISCLAIMER

The Government of Malaysia and the National Pharmaceutical Regulatory Agency are not responsible for any loss or damage caused by the usage of any information obtained from this website.

Mobile Web :

Site Last Modified

  • Last Modified: Khamis 29 September 2022, 09:59:13.
© Copyright 2018 . All Rights Reserved National Pharmaceutical Regulatory Agency NPRA

Search

Menu Utama